Connection
Shi-Ming Tu to Immunotherapy
This is a "connection" page, showing publications Shi-Ming Tu has written about Immunotherapy.
|
|
Connection Strength |
|
|
|
|
|
0.504 |
|
|
|
-
Bilen MA, Hess KR, Subudhi SK, Aparicio A, Kim J, Zurita-Saavedra AJ, Araujo JC, Corn PG, Stover J, Lin SH, Logothetis CJ, Tu SM. Clinical predictors of survival in patients with castration-resistant prostate cancer receiving sipuleucel-T cellular immunotherapy. Cancer Chemother Pharmacol. 2017 Sep; 80(3):583-589.
Score: 0.504